Halozyme Therapeutics, Inc. (NASDAQ:HALO) announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on patient enrollment and dosing of PEGPH20 in the ongoing Phase 2 trial (Study 202) evaluating PEGPH20 in patients with pancreatic cancer permitting the study to resume under a revised protocol. Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock opened today at $9.37 and is currently trading at $9.46. The stock showed a positive weekly performance of 0.87%.
Verint Systems Inc. (NASDAQ:VRNT) advanced 9.2% after the firm beat forecasts for first quarter earnings. Verint Systems Inc. (NASDAQ:VRNT) stock opened at $51.69, in current trading session and currently is at $52.68, by gaining 13.07%. The 52 week range of $32.80 – $53.00. Company’s market capitalization is 2.85 billion.
ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), which is said to be a market leader of antisense therapeutics, on June 4, 2014 announced that the ISIS Pharmaceuticals’ management will present the overview of the company at the Goldman Sachs 35th Annual Global Healthcare Conference. This will take place on June 11, 2014 at 8:40 a.m. PT in Rancho Palos Verdes, CA. ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) stock is currently trading at $29.28. The EPS of the stock is -0.78. Company’s market capitalization is 3.44 billion.
Finisar Corporation (NASDAQ:FNSR), a global technology leader in high-speed optical communications, confirmed that it will announce its fiscal fourth quarter 2014 financial results for the period ending April 27, 2014, at the close of market on Thursday, June 12th, 2014. Finisar Corporation (NASDAQ:FNSR) stock opened the session at $23.90, and now is at $23.37. The 52 week range of the Finisar Corporation (NASDAQ:FNSR) stock remained $12.71 – $28.85 and the day range was $23.37 – $23.90.
JDS Uniphase Corp. (NASDAQ:JDSU) recently announced that they would be engaging in a $100 million share buyback program. This move has been prompted by the steady decline of the share value at the courses. JDS Uniphase Corp (NASDAQ:JDSU) stock opened today at $11.02 and is currently trading at $10.92. The stock showed a negative weekly performance of -3.76%.